Influenza Vaccine Randomized Educational Trial: Adult

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02907645

Enrollment

222

Registered

2016-09-20

Start date

2016-10-06

Completion date

2017-06-01

Last updated

2017-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza, Vaccination

Brief summary

Influenza vaccine is recommended as routine care for all individuals who are at least 6 months of age and older. Recently, questions about vaccine safety and concerns for side effects have increased, contributing to both influenza vaccine hesitancy and refusal. In an effort to educate patients, public health entities and physicians give informational handouts in various forms. However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. The purpose of this study is to compare the effectiveness of pro-vaccine messages of local data, pro-vaccine messages of national data, and no educational message on patient's receipt of the influenza vaccine. These results will help to understand the relationship between patient education and the intent to vaccinate and receipt of the influenza vaccine as well as to optimize educational information given to patients regarding the influenza vaccine.

Interventions

BEHAVIORALLocal educational information

Adult patients in this arm receive educational information regarding influenza vaccination based on local data

BEHAVIORALNational educational information

Adult patients in this arm receive educational information regarding influenza vaccination based on national data

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* visit to study site at time of intervention

Exclusion criteria

* prior receipt of influenza vaccine that season

Design outcomes

Primary

Measure	Time frame	Description
Number of participants who receive influenza vaccination on day of intervention	Day 0	Receipt of influenza vaccination on the day of the educational intervention

Secondary

Measure	Time frame	Description
Number of participants who receive Influenza vaccination by the end of the influenza vaccine season	Up to 7 months	Receipt of influenza vaccination by April 2017

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026